Patents Assigned to AOP ORPHAN IP AG
  • Glycosidic derivatives of treprostinil
    Patent number: 11427609
    Abstract: The present invention relates to the field of pharmaceutical products, specifically the glycosidic derivatives of treprostinil. The glycosidic treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Grant
    Filed: December 13, 2018
    Date of Patent: August 30, 2022
    Assignee: AOP ORPHAN IP AG
    Inventors: Josef Spreitz, Wolfgang Strohmaier
  • GLYCOSIDIC DERIVATIVES OF TREPROSTINIL
    Publication number: 20210087216
    Abstract: The present invention relates to the field of pharmaceutical products, specifically the glycosidic derivatives of treprostinil. The glycosidic treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: December 13, 2018
    Publication date: March 25, 2021
    Applicant: AOP ORPHAN IP AG
    Inventors: Josef SPREITZ, Wolfgang STROHMAIER
  • Compositions for use in cardioplegia comprising esmolol and adenosine
    Patent number: 10420786
    Abstract: The invention related to a composition for use in cardioplegia, said composition comprising (i) esmolol; and (ii) adenosine, wherein in use the concentration of said esmolol is in the range 0.3-1.5 mM, and wherein in use the concentration of said adenosine is in the range 0.1-1.5 mM. The invention also relates to methods of making and using such compositions.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: September 24, 2019
    Assignee: AOP ORPHAN IP AG
    Inventors: Hazem B. Fallouh, Jonathan C. Kentish, David J. Chambers